You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global and United States Transcriptomics Market Size, Status and Forecast 2021-2027

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.

North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
Market Analysis and Insights: Global Transcriptomics Market
The global Transcriptomics market size is projected to reach US$ 6688.1 million by 2027, from US$ 3431.2 million in 2020, at a CAGR of 10.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transcriptomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transcriptomics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transcriptomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transcriptomics market.
Transcriptomics Breakdown Data by Type
PCR
Microarray
Sequencing
Sequencing type proportion is 45.4% at most
Transcriptomics Breakdown Data by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
Academic research and government agencies use it the most
Based on regional and country-level analysis, the Transcriptomics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Transcriptomics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.

The following players are covered in this report:
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptomics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 Microarray
1.2.4 Sequencing
1.3 Market by Application
1.3.1 Global Transcriptomics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Transcriptomics Market Perspective (2016-2027)
2.2 Transcriptomics Growth Trends by Regions
2.2.1 Transcriptomics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Transcriptomics Historic Market Share by Regions (2016-2021)
2.2.3 Transcriptomics Forecasted Market Size by Regions (2022-2027)
2.3 Transcriptomics Industry Dynamic
2.3.1 Transcriptomics Market Trends
2.3.2 Transcriptomics Market Drivers
2.3.3 Transcriptomics Market Challenges
2.3.4 Transcriptomics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Transcriptomics Players by Revenue
3.1.1 Global Top Transcriptomics Players by Revenue (2016-2021)
3.1.2 Global Transcriptomics Revenue Market Share by Players (2016-2021)
3.2 Global Transcriptomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Transcriptomics Revenue
3.4 Global Transcriptomics Market Concentration Ratio
3.4.1 Global Transcriptomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptomics Revenue in 2020
3.5 Transcriptomics Key Players Head office and Area Served
3.6 Key Players Transcriptomics Product Solution and Service
3.7 Date of Enter into Transcriptomics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Transcriptomics Breakdown Data by Type
4.1 Global Transcriptomics Historic Market Size by Type (2016-2021)
4.2 Global Transcriptomics Forecasted Market Size by Type (2022-2027)

5 Transcriptomics Breakdown Data by Application
5.1 Global Transcriptomics Historic Market Size by Application (2016-2021)
5.2 Global Transcriptomics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Transcriptomics Market Size (2016-2027)
6.2 North America Transcriptomics Market Size by Type
6.2.1 North America Transcriptomics Market Size by Type (2016-2021)
6.2.2 North America Transcriptomics Market Size by Type (2022-2027)
6.2.3 North America Transcriptomics Market Size by Type (2016-2027)
6.3 North America Transcriptomics Market Size by Application
6.3.1 North America Transcriptomics Market Size by Application (2016-2021)
6.3.2 North America Transcriptomics Market Size by Application (2022-2027)
6.3.3 North America Transcriptomics Market Size by Application (2016-2027)
6.4 North America Transcriptomics Market Size by Country
6.4.1 North America Transcriptomics Market Size by Country (2016-2021)
6.4.2 North America Transcriptomics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Transcriptomics Market Size (2016-2027)
7.2 Europe Transcriptomics Market Size by Type
7.2.1 Europe Transcriptomics Market Size by Type (2016-2021)
7.2.2 Europe Transcriptomics Market Size by Type (2022-2027)
7.2.3 Europe Transcriptomics Market Size by Type (2016-2027)
7.3 Europe Transcriptomics Market Size by Application
7.3.1 Europe Transcriptomics Market Size by Application (2016-2021)
7.3.2 Europe Transcriptomics Market Size by Application (2022-2027)
7.3.3 Europe Transcriptomics Market Size by Application (2016-2027)
7.4 Europe Transcriptomics Market Size by Country
7.4.1 Europe Transcriptomics Market Size by Country (2016-2021)
7.4.2 Europe Transcriptomics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Transcriptomics Market Size (2016-2027)
8.2 Asia-Pacific Transcriptomics Market Size by Type
8.2.1 Asia-Pacific Transcriptomics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Transcriptomics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Transcriptomics Market Size by Type (2016-2027)
8.3 Asia-Pacific Transcriptomics Market Size by Application
8.3.1 Asia-Pacific Transcriptomics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Transcriptomics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Transcriptomics Market Size by Application (2016-2027)
8.4 Asia-Pacific Transcriptomics Market Size by Region
8.4.1 Asia-Pacific Transcriptomics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Transcriptomics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Transcriptomics Market Size (2016-2027)
9.2 Latin America Transcriptomics Market Size by Type
9.2.1 Latin America Transcriptomics Market Size by Type (2016-2021)
9.2.2 Latin America Transcriptomics Market Size by Type (2022-2027)
9.2.3 Latin America Transcriptomics Market Size by Type (2016-2027)
9.3 Latin America Transcriptomics Market Size by Application
9.3.1 Latin America Transcriptomics Market Size by Application (2016-2021)
9.3.2 Latin America Transcriptomics Market Size by Application (2022-2027)
9.3.3 Latin America Transcriptomics Market Size by Application (2016-2027)
9.4 Latin America Transcriptomics Market Size by Country
9.4.1 Latin America Transcriptomics Market Size by Country (2016-2021)
9.4.2 Latin America Transcriptomics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Transcriptomics Market Size (2016-2027)
10.2 Middle East & Africa Transcriptomics Market Size by Type
10.2.1 Middle East & Africa Transcriptomics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Transcriptomics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Transcriptomics Market Size by Type (2016-2027)
10.3 Middle East & Africa Transcriptomics Market Size by Application
10.3.1 Middle East & Africa Transcriptomics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Transcriptomics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Transcriptomics Market Size by Application (2016-2027)
10.4 Middle East & Africa Transcriptomics Market Size by Country
10.4.1 Middle East & Africa Transcriptomics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Transcriptomics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Transcriptomics Introduction
11.1.4 Thermo Fisher Scientific Revenue in Transcriptomics Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Transcriptomics Introduction
11.2.4 Illumina Revenue in Transcriptomics Business (2016-2021)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Transcriptomics Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Transcriptomics Business (2016-2021)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptomics Introduction
11.4.4 Agilent Technologies Revenue in Transcriptomics Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Transcriptomics Introduction
11.5.4 Roche Revenue in Transcriptomics Business (2016-2021)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Transcriptomics Introduction
11.6.4 GE Healthcare Revenue in Transcriptomics Business (2016-2021)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Transcriptomics Introduction
11.7.4 Bio-Rad Laboratories Revenue in Transcriptomics Business (2016-2021)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Details
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Transcriptomics Introduction
11.8.4 Fluidigm Revenue in Transcriptomics Business (2016-2021)
11.8.5 Fluidigm Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140